Recent Diabetes articles in the Big 4

We have full text access to BMJ, NEJM and JAMA
Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan

Metabolic syndrome—what is the clinical usefulness?
...events or diabetes in elderly patients, shows that a fasting plasma glucose test is as good as or potentially better than a diagnosis of the metabolic syndrome for predicting diabetes. They also show that a diagnosis of the metabolic syndrome has negligible association with risk of cardiovascular disease; and that the whole is not greater than t...
The Lancet - 10:54 AM (4 hours ago)

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
...disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations.
The Lancet - 10:54 AM (4 hours ago)

[PRACTICE] Management of type 2 diabetes: summary of updated NICE guidance
BMJ current issue - 12:06 AM (14 hours ago)

[LETTERS] Screen women with gestational diabetes for type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)

[PRACTICE] Commentary: controversies in NICE guidance on management of type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)

CME: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
(No abstract is available for this citation)
New England Journal of Medicine - Jun 4, 2008 (2 days ago)

ORIGINAL ARTICLE: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
...type 2 diabetes and nephropathy received either aliskiren, an oral direct renin inhibitor, or placebo, in addition to the maximal recommended dose of losartan and optimal antihypertensive therapy. Aliskiren was associated with a reduction in the mean urinary albumin-to-creatinine ratio. This direct renin inhibitor may be renoprotective independe...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)

EDITORIAL: Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
The discovery 110 years ago that crude kidney extract elicited a pressor reaction provided the first evidence of the existence of the renin-angiotensin-aldosterone system, a major vasoactive system,1 and the ...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)

CLINICAL CROSSROADS: A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
...type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, in...
JAMA current issue - Jun 3, 2008 (3 days ago)

JAMA PATIENT PAGE: Pregnancy and Diabetes
JAMA current issue - Jun 3, 2008 (3 days ago)

ORIGINAL CONTRIBUTION: Patient-Important Outcomes in Registered Diabetes Trials
...efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outc...
JAMA current issue - Jun 3, 2008 (3 days ago)

Department of Error
...diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736–43—In this Article (March 1), data in the sensitivity and specificity columns of were incorrect, as was the total number of participants above the cutoff of 5·6 mmol/L in the Australian Diabetes, Obesity and Lifestyle Study. The corrected version of the...
The Lancet - May 30, 2008 10:43 AM

CORRECTIONS: Gestational Diabetes -- Setting Limits, Exploring Treatments
...Gestational Diabetes -- Setting Limits, Exploring Treatments . In the paragraph that begins "Also in this issue of the Journal..." (page 2062), the final sentence should have read, "Rates of ...
New England Journal of Medicine - May 28, 2008 10:20 PM

LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM

LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM

LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM

LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply
JAMA current issue - May 27, 2008 9:27 PM

BOOK AND MEDIA REVIEWS: Levin and O'Neal's The Diabetic Foot
JAMA current issue - May 27, 2008 9:27 PM

LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM